Therefore, we selected the RPS6KA1 and LMCD1 genes as diagnostic for steatosis and AS, and the RPS6KA1 SYNP02, JAML and SERPINA3 genes as diagnostic for NASH and AS. Here, RPS6KA1 is linked to metabolic dysfunction-associated steatohepatitis.